FcR-Mediated Effector Function Contributes to the Therapeutic Response of Anti-TNF Monoclonal Antibodies in a Mouse Model of IBD

被引：0
|
作者：
Levin, Alon D.
Wildenberg, Manon E.
D'Haens, Geert R.
van den Brink, Gijs R.
机构：
来源：
GASTROENTEROLOGY | 2014年 / 146卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Mo1693
引用
收藏
页码：S637 / S638
页数：2
相关论文
共 26 条
  • [1] FcR-mediated effector function contributes to the therapeutic response of anti-TNF monoclonal antibodies in a mouse model of IBD
    Levin, A.
    Wildenberg, M.
    D'Haens, G.
    van den Brink, G.
    [J]. JOURNAL OF CROHNS & COLITIS, 2014, 8 : S16 - S16
  • [2] Fc Receptor-mediated Effector Function Contributes to the Therapeutic Response of Anti-TNF Monoclonal Antibodies in a Mouse Model of Inflammatory Bowel Disease
    McRae, Bradford L.
    Levin, Alon D.
    Wildenberg, Manon E.
    Koelink, Pim J.
    Bousquet, Peter
    Mikaelian, Igor
    Sterman, Annette Schwartz
    Bryant, Shaughn
    D'Haens, Geert
    Kamath, Rajesh
    Salfeld, Jochen
    van den Brink, Gijs R.
    [J]. JOURNAL OF CROHNS & COLITIS, 2016, 10 (01): : 69 - 76
  • [3] Gastrointestinal stability of therapeutic anti-TNF α IgG1 monoclonal antibodies
    Yadav, Vipul
    Varum, Felipe
    Bravo, Roberto
    Furrer, Esther
    Basit, Abdul W.
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2016, 502 (1-2) : 181 - 187
  • [4] Anti-TNF Antibodies and Autophagy: A Hidden Nexus for a Successful Therapeutic Response?
    Genua, Marco
    Becker, Christoph
    Vetrano, Stefania
    [J]. JOURNAL OF CROHNS & COLITIS, 2016, 10 (03): : 237 - 238
  • [5] Is There a Role for Therapeutic Drug Monitoring of Anti-TNF Monoclonal Antibodies in Inflammatory Bowel Disease
    Baert, Filip
    [J]. DIGESTIVE DISEASES, 2015, 33 : 70 - 77
  • [6] The antibody response against human and chimeric anti-TNF therapeutic antibodies primarily targets the TNF binding region
    van Schie, K. A.
    Hart, M. H.
    de Groot, E. R.
    Kruithof, S.
    Aarden, L. A.
    Wolbink, G. J.
    Rispens, T.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 (01) : 311 - 314
  • [7] The antibody response against human and chimeric anti-TNF therapeutic antibodies primarily targets the TNF binding region
    Rinaudo-Gaujous, M.
    Roblin, X.
    Marotte, H.
    Paul, S.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 (08)
  • [8] Presence of Anti-drug Antibodies Does Not Reduce the Efficacy of an Oral Anti-TNF Antibody in a Murine IBD Model
    Bhol, Kailash
    Erlich, Emma
    Lemos, Brenda
    Tracey, Daniel
    Hartman, Deborah
    Fox, Barbara
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2013, 108 : S545 - S546
  • [9] Interest in the addition of azathioprine (AZA) to the switch of anti-TNF in IBD patients in loss of response with undetectable anti-TNF trough levels and anti-drug antibodies: A prospective randomised trial
    Roblin, X.
    Paul, S.
    Boschetti, G.
    Phelip, J. M.
    Del Tedesco, E.
    Berger, A.
    Nancey, S.
    Williet, N.
    Flourie, B.
    [J]. JOURNAL OF CROHNS & COLITIS, 2018, 12 : S414 - S415
  • [10] Anti-TNF therapy preserves bladder barrier function in a mouse model of neurogenic cystitis
    Chen, MC
    Klumpp, DJ
    [J]. JOURNAL OF UROLOGY, 2006, 175 (04): : 96 - 96
123